Cargando…

Efficacy and safety of rituximab treatment in patients with idiopathic inflammatory myopathies: A systematic review and meta-analysis

OBJECTIVE: Idiopathic inflammatory myopathies (IIMs) are a heterogeneous group of autoimmune diseases with various subtypes, myositis-specific antibodies, and affect multiple systems. The treatment of IIMs remains challenging, especially for refractory myositis. In addition to steroids and tradition...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhen, Chao, Hou, Ying, Zhao, Bing, Ma, Xiaotian, Dai, Tingjun, Yan, Chuanzhu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9791086/ https://www.ncbi.nlm.nih.gov/pubmed/36578492 http://dx.doi.org/10.3389/fimmu.2022.1051609

Ejemplares similares

Juvenile idiopathic inflammatory myopathies with anti‐3‐hydroxy‐3‐methylglutaryl‐coenzyme A reductase antibodies in a Chinese cohort
por: Hou, Ying, et al.
Publicado: (2021)

Efficacy and Safety of Rituximab in Korean Patients with Refractory Inflammatory Myopathies
por: Ahn, Ga Young, et al.
Publicado: (2020)

The Efficacy and Safety of Rituximab in Patients with Idiopathic Inflammatory Myopathy-Associated Interstitial Lung Disease: Case Series
por: Jang, Youngeun, et al.
Publicado: (2023)

Predictors of cardiac involvement in idiopathic inflammatory myopathies
por: Bandeira, Matilde, et al.
Publicado: (2023)

Idiopathic inflammatory myopathy and non-coding RNA
por: Yang, Yang, et al.
Publicado: (2023)

A Path to Prediction of Outcomes in Juvenile Idiopathic Inflammatory Myopathy
por: Reed, Ann Marie, et al.
Publicado: (2019)

Programmed Cell Death Pathways in the Pathogenesis of Idiopathic Inflammatory Myopathies
por: Shi, Jia, et al.
Publicado: (2021)

Anti-rituximab antibodies in patients with refractory autoimmune nodopathy with anti-neurofascin-155 antibody
por: Bai, Yunfei, et al.
Publicado: (2023)

Effect of low-dose rituximab treatment on autoimmune nodopathy with anti-contactin 1 antibody
por: Hou, Ying, et al.
Publicado: (2022)

High-Dimensional Analysis Reveals Distinct Endotypes in Patients With Idiopathic Inflammatory Myopathies
por: Wilfong, Erin M., et al.
Publicado: (2022)

Deciphering the crosstalk of immune dysregulation between COVID-19 and idiopathic inflammatory myopathy
por: Zhang, Zhao, et al.
Publicado: (2023)

Clinicopathologic Profiles of Sporadic Late-Onset Nemaline Myopathy: Practical Importance of Anti–α-Actinin Immunostaining
por: Zhao, Bing, et al.
Publicado: (2022)

Serum metabolomic analysis reveals disorder of steroid hormone biosynthesis in patients with idiopathic inflammatory myopathy
por: Huo, Tong, et al.
Publicado: (2023)

Decreased Serum 25-(OH)-D Level Associated With Muscle Enzyme and Myositis Specific Autoantibodies in Patients With Idiopathic Inflammatory Myopathy
por: Yu, Zhen, et al.
Publicado: (2021)

Efficacy and Safety of Rituximab in the Treatment of Idiopathic Membranous Nephropathy: A Meta-Analysis
por: Lu, Huijuan, et al.
Publicado: (2022)

Efficacy and safety of rituximab for primary membranous nephropathy with different clinical presentations: a retrospective study
por: Zhang, Shasha, et al.
Publicado: (2023)

Autoantibodies in the pathogenesis of idiopathic inflammatory myopathies: Does the endoplasmic reticulum stress response have a role?
por: Corona-Sanchez, Esther Guadalupe, et al.
Publicado: (2022)

Muscle fiber necroptosis in pathophysiology of idiopathic inflammatory myopathies and its potential as target of novel treatment strategy
por: Kamiya, Mari, et al.
Publicado: (2023)

Systematic Review of Safety and Efficacy of Rituximab in Treating Immune-Mediated Disorders
por: Kaegi, Celine, et al.
Publicado: (2019)

Resistin in idiopathic inflammatory myopathies
por: Filková, Mária, et al.
Publicado: (2012)

Malignancy and Idiopathic Inflammatory Myopathies
por: Ungprasert, Patompong, et al.
Publicado: (2013)

Idiopathic inflammatory myopathies and the lung
por: Lega, Jean-Christophe, et al.
Publicado: (2015)

Efficacy of Rituximab in Refractory Inflammatory Myopathy Associated With Coexistence of Behçet’s Disease and Antiphospholipid Syndrome
por: Guiomar, Verónica, et al.
Publicado: (2019)

Retracted: Efficacy and Safety of Rituximab in the Treatment of Idiopathic Membranous Nephropathy: A Meta-Analysis
por: and Biomechanics, Applied Bionics
Publicado: (2023)

Role of Immunoglobulins in Muscular Dystrophies and Inflammatory Myopathies
por: Farini, Andrea, et al.
Publicado: (2021)

Hsp90 Levels in Idiopathic Inflammatory Myopathies and Their Association With Muscle Involvement and Disease Activity: A Cross-Sectional and Longitudinal Study
por: Štorkánová, Hana, et al.
Publicado: (2022)

Imaging biomarkers in the idiopathic inflammatory myopathies
por: Zubair, Adeel S., et al.
Publicado: (2023)

Cardiovascular manifestations in idiopathic inflammatory myopathies
por: Shah, Meera, et al.
Publicado: (2023)

Effectiveness and Safety of Rituximab in Recalcitrant Pemphigoid Diseases
por: Lamberts, Aniek, et al.
Publicado: (2018)

Necrotizing Autoimmune Myopathy: A Rare Variant of Idiopathic Inflammatory Myopathies
por: Khan, Noman Ahmed Jang, et al.
Publicado: (2017)

Type 1 interferon signature in peripheral blood mononuclear cells and monocytes of idiopathic inflammatory myopathy patients with different myositis-specific autoantibodies
por: Li, Mengdi, et al.
Publicado: (2023)

The Safety and Efficacy of Rituximab and Belimumab in Systemic Lupus Erythematosus: A Systematic Review
por: Abid, Naushad, et al.
Publicado: (2023)

Immune mechanisms in the pathogenesis of idiopathic inflammatory myopathies
por: Grundtman, Cecilia, et al.
Publicado: (2007)

Recent advances in the immunogenetics of idiopathic inflammatory myopathy
por: Chinoy, Hector, et al.
Publicado: (2011)

Idiopathic Inflammatory Myopathies: Clinical Approach and Management
por: Malik, Asma, et al.
Publicado: (2016)

Drugs in induction and treatment of idiopathic inflammatory myopathies
por: Iaccarino, Luca, et al.
Publicado: (2014)

The Clinical Phenotypes of the Juvenile Idiopathic Inflammatory Myopathies
por: Shah, Mona, et al.
Publicado: (2013)

Idiopathic inflammatory myopathies overlapping with systemic diseases
por: Lepreux, Sébastien, et al.
Publicado: (2018)

Disease Specific Autoantibodies in Idiopathic Inflammatory Myopathies
por: Stuhlmüller, Bruno, et al.
Publicado: (2019)

Coexistence of Axial Spondyloarthritis and Idiopathic Inflammatory Myopathy
por: Ge, Yongpeng, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_n1oipvlg3sjq9euu2oj352q1i4